Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals (Jameel/Manufacturing Biopharmaceuticals) || Strategies for Bulk Storage and Shipment of Proteins
- 作者Jameel, Feroz; Hershenson, Susan
- 文件大小1834.23KB
- 发表时间2010
- DOI10.1002/9780470595886.ch27
- 页码677-704
Switching from Calcium Carbonate to Sevelamer Hydrochloride Has Suppressive Effects on the Progression of Aortic Calcificationin Hemodialysis Patients: Assessment Using Plain Chest X-Ray FilmsIzumi, Masaaki; Morita, Syunpei; Nishian, Yoshihiko; Miyamoto, Takashi; Kasumoto, Hiroomi; Oue, Mai; Hori, Kahori; Kitamura, Rie; Yamamoto, Satoshi; Nakanishi, Takeshi · Renal Failure · 2008
Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosisHatakeyama, Shingo; Murasawa, Hiromi; Narita, Takuma; Oikawa, Masaaki; Fujita, Naoki; Iwamura, Hiromichi; Mikami, Joutaro; Kojima, Yuta; Sato, Tendo; Fukushi, Ken; Ishibashi, Yusuke; Hashimoto, Yasuhiro; Koie, Takuya; Saitoh, Hisao; Funyu, Tomihisa; Ohyama, Chikara · BMC Nephrology · 2013
Upcoming MeetingsTherapeutic Apheresis and Dialysis · 2012
Upcoming MeetingsTherapeutic Apheresis and Dialysis · 2012
Acknowledgment of ReviewersTherapeutic Apheresis and Dialysis · 2012
Upcoming MeetingsTherapeutic Apheresis and Dialysis · 2013
Upcoming MeetingsTherapeutic Apheresis and Dialysis · 2014
Adiponectin Levels in Hemodialysis PatientsBalta, Sevket; Ozturk, Cengiz; Demirkol, Sait; Demir, Mustafa · Therapeutic Apheresis and Dialysis · 2014
PrefaceKoiwa, Fumihiko · Therapeutic Apheresis and Dialysis · 2013
CorrigendumTherapeutic Apheresis and Dialysis · 2014